Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

East Carolina Cardiovascular Symposium 2020: Updates in Cardiovascular Medicine: Conference Topics 8 - 10 am

October 14, 2020

Conference Brochure

                                                                                                                                       

The Impact of COVID19 Pandemic on Cardiovascular Medicine

1.

Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.

Samidurai A, Das A.

Int J Mol Sci. 2020 Sep 16;21(18):E6790. doi: 10.3390/ijms21186790.

PMID: 32947927 Review.

2.

COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients.

Bianco M, Biolè CA, Campagnuolo S, Pietrangiolillo F, Spirito A, Galluzzo A, Nuñez-Gil I, Destefanis P, Luciano A, Carvalho P, Varalda GP, Previti A, Gravellone M, Travieso Gonzalez A, Ugo F, Pivano G, Rametta F, Perboni A, Pozzi R, Montagna L, Cerrato E.

Int J Cardiol Heart Vasc. 2020 Sep 11;30:100637. doi: 10.1016/j.ijcha.2020.100637. Online ahead of print.

PMID: 32953967 Free PMC article.

3.

Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach.

Oliveros E, Brailovsky Y, Scully P, Nikolou E, Rajani R, Grapsa J.

Card Fail Rev. 2020 Aug 14;6:e22. doi: 10.15420/cfr.2020.09. eCollection 2020 Mar.

PMID: 32944292 Free PMC article. Review.

4.

Treatment of Coronavirus Disease 2019: Shooting in the Dark.

Tamargo J.

Eur Cardiol. 2020 Aug 10;15:e59. doi: 10.15420/ecr.2020.21. eCollection 2020 Feb.

PMID: 32944088 Free PMC article. Review.

5.

Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Shah S, Diwan S, Soin A, Rajput K, Mahajan A, Manchikanti L, Kaye AD, Hirsch JA, Gharibo C.

Pain Physician. 2020 Aug;23(4S):S161-S182.

PMID: 32942784

6.

Short- and Potential Long-term Adverse Health Outcomes of COVID-19: A Rapid Review.

Leung T, Chan A, Chan EW, Chan V, Chui C, Cowling BJ, Gao L, Ge MQ, Hung I, Ip M, Ip P, Lau KK, Lau CS, Lau L, Leung WK, Li X, Luo H, Man K, Ng V, Siu CW, Wan E, Wing YK, Wong C, Wong K, Wong I.

Emerg Microbes Infect. 2020 Sep 17:1-19. doi: 10.1080/22221751.2020.1825914. Online ahead of print.

PMID: 32940572

7.

Identifying common baseline clinical features of COVID-19: a scoping review.

Ferreira-Santos D, Maranhão P, Monteiro-Soares M; COVIDcids.

BMJ Open. 2020 Sep 16;10(9):e041079. doi: 10.1136/bmjopen-2020-041079.

PMID: 32938604

8.

Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment.

Ye Q, Lu D, Shang S, Fu J, Gong F, Shu Q, Mao J.

ESC Heart Fail. 2020 Sep 16. doi: 10.1002/ehf2.12960. Online ahead of print.

PMID: 32935928 Review.

9.

Correction: Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings.

Prabhakaran D, Perel P, Roy A, Singh K, Raspail L, Faria-Neto JR, Gidding SS, Ojji D, Hakim F, Newby LK, Stępińska J, Lam CSP, Jobe M, Kraus S, Chuquiure-Valenzuela E, Piñeiro D, Khaw KT, Bahiru E, Banerjee A, Narula J, Pinto FJ, Wood DA, Sliwa K.

Glob Heart. 2020 Aug 7;15(1):54. doi: 10.5334/gh.885.

PMID: 32925986 Free PMC article.

10.

Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings.

Prabhakaran D, Perel P, Roy A, Singh K, Raspail L, Faria-Neto JR, Gidding SS, Ojji D, Hakim F, Newby LK, Stępińska J, Lam CSP, Jobe M, Kraus S, Chuquiure-Valenzuela E, Piñeiro D, Khaw KT, Bahiru E, Banerjee A, Narula J, Pinto FJ, Wood DA, Sliwa K.

Glob Heart. 2020 Jul 1;15(1):44. doi: 10.5334/gh.823.

PMID: 32923338 Free PMC article.

Updates in Structural Heart Disease

1.

Structural heart disease: the revolution.

Hernandez-Vaquero D.

Ann Transl Med. 2020 Aug;8(15):954. doi: 10.21037/atm.2020.01.48.

PMID: 32953754 Free PMC article. No abstract available.

2.

Malignant Ventricular Arrhythmias in Patients with Severe Acute Respiratory Distress Syndrome Due to COVID-19 without Significant Structural Heart Disease.

Abrams MP, Coromilas EJ, Wan EY, Rubin GA, Garan H, Dizon JM.

HeartRhythm Case Rep. 2020 Aug 25. doi: 10.1016/j.hrcr.2020.08.017. Online ahead of print.

PMID: 32864335 Free PMC article. No abstract available.

3.

Contact-force monitoring increases accuracy of right ventricular voltage mapping avoiding "false scar" detection in patients with no evidence of structural heart disease.

Sciarra L, Palamà Z, Nesti M, Lanzillo C, Di Roma M, De Ruvo E, Robles AG, Cavarretta E, Scarà A, De Luca L, Grieco D, Rillo M, Romano S, Petroni R, Penco M, Calò L.

Indian Pacing Electrophysiol J. 2020 Aug 6:S0972-6292(20)30084-X. doi: 10.1016/j.ipej.2020.07.004. Online ahead of print.

PMID: 32768620

4.

Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic.

Khan JM, Khalid N, Shlofmitz E, Forrestal BJ, Yerasi C, Case BC, Chezar-Azerrad C, Musallam A, Rogers T, Waksman R.

Cardiovasc Revasc Med. 2020 May 30:S1553-8389(20)30345-6. doi: 10.1016/j.carrev.2020.05.040. Online ahead of print.

PMID: 32736981 Free PMC article. Review.

5.

Sudden cardiac death in children and young adults without structural heart disease: a comprehensive review.

Tsuda T, Fitzgerald KK, Temple J.

Rev Cardiovasc Med. 2020 Jun 30;21(2):205-216. doi: 10.31083/j.rcm.2020.02.55.

PMID: 32706209 Review.

6.

Cardiac Computed Tomography for Structural Heart Disease Assessment and Therapeutic Planning: Focus on Prosthetic Valve Dysfunction.

Senapati A, Faza NN, Mahmarian J, Chang SM.

Methodist Debakey Cardiovasc J. 2020 Apr-Jun;16(2):86-96. doi: 10.14797/mdcj-16-2-86.

PMID: 32670468 Free PMC article. Review.

7.

Performing Structural Heart Disease Interventions During the COVID-19 Pandemic: But What Are the Downsides?

Li WWL, van Garsse LAFM, van Wely MH, Morshuis WJ, van Royen N.

JACC Cardiovasc Interv. 2020 Jul 13;13(13):1606-1607. doi: 10.1016/j.jcin.2020.05.007. Epub 2020 May 12.

PMID: 32646704 Free PMC article. No abstract available.

8.

Structural heart disease: the year in valvular and complex coronary intervention trials.

Lugo D, Pulido Ramirez AL, Lo Presti S, Nappi F, Mihos CG.

J Thorac Dis. 2020 May;12(5):2910-2918. doi: 10.21037/jtd.2019.12.138.

PMID: 32642203 Free PMC article. Review.

9.

Coronary and structural heart disease interventions during COVID-19 pandemic: A road map for clinicians and health care delivery systems.

Harjai KJ, Agarwal S, Bauch T, Bernardi M, Casale AS, Green S, Harostock M, Ierovante N, Mascarenhas V, Matsumura M, Nawaz Y, Scott T, Singh D, Stella JJ, Vijayaraman P, Yost G, Blankenship JC.

Cardiovasc Revasc Med. 2020 Jun 10:S1553-8389(20)30362-6. doi: 10.1016/j.carrev.2020.06.013. Online ahead of print.

PMID: 32586744 Free PMC article.

10.

Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic.

Giordano A, Biondi-Zoccai G, Frati G, Bartorelli AL.

Curr Atheroscler Rep. 2020 Jun 10;22(7):29. doi: 10.1007/s11883-020-00849-5.

PMID: 32524266 Free PMC article. Review.

Updates in General Heart Failure

1.

Effects of Pimobendan on Prolonging Time to Rehospitalization or Frequency of Rehospitalization in Patients with Heart Failure: A Retrospective Cohort Study Using a Medical Administrative Database (PREFER Study).

Kodama K, Murata T, Dohi N, Nakano M, Yokoi T, Sakamoto T, Nakao K.

J Health Econ Outcomes Res. 2020 Jun 23;7(1):71-84. doi: 10.36469/jheor.2020.13246. eCollection 2020.

PMID: 32685600 Free PMC article.

2.

Echocardiographic Assessment of Right Ventriculo-arterial Coupling: Clinical Correlates and Prognostic Impact in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy.

Bragança B, Trêpa M, Santos R, Silveira I, Fontes-Oliveira M, Sousa MJ, Reis H, Torres S, Santos M.

J Cardiovasc Imaging. 2020 Apr;28(2):109-120. doi: 10.4250/jcvi.2019.0094. Epub 2020 Jan 21.

PMID: 32052609 Free PMC article.

3.

Bioimpedance Alerts from Cardiovascular Implantable Electronic Devices: Observational Study of Diagnostic Relevance and Clinical Outcomes.

Smeets CJ, Vranken J, Van der Auwera J, Verbrugge FH, Mullens W, Dupont M, Grieten L, De Cannière H, Lanssens D, Vandenberk T, Storms V, Thijs IM, Vandervoort PM.

J Med Internet Res. 2017 Nov 23;19(11):e393. doi: 10.2196/jmir.8066.

PMID: 29170147 Free PMC article.

4.

Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.

Lawson CA, Jones PW, Teece L, Dunbar SB, Seferovic PM, Khunti K, Mamas M, Kadam UT.

JACC Heart Fail. 2018 Jan;6(1):18-26. doi: 10.1016/j.jchf.2017.08.020. Epub 2017 Oct 11.

PMID: 29032131 Clinical Trial.

5.

Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.

Bayés-Genis A, Lanfear DE, de Ronde MWJ, Lupón J, Leenders JJ, Liu Z, Zuithoff NPA, Eijkemans MJC, Zamora E, De Antonio M, Zwinderman AH, Pinto-Sietsma SJ, Pinto YM.

Eur J Heart Fail. 2018 Jan;20(1):67-75. doi: 10.1002/ejhf.984. Epub 2017 Sep 26.

PMID: 28949058

6.

Dying With a Left Ventricular Assist Device as Destination Therapy.

Dunlay SM, Strand JJ, Wordingham SE, Stulak JM, Luckhardt AJ, Swetz KM.

Circ Heart Fail. 2016 Oct;9(10):e003096. doi: 10.1161/CIRCHEARTFAILURE.116.003096.

PMID: 27758809 Free PMC article.